Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Cantor Fitzgerald healthcare analysts hold analyst/industry conference call » 16:43
07/22/21
07/22
16:43
07/22/21
16:43
PRTA

Prothena

$51.46 /

-0.37 (-0.71%)

, LLY

Eli Lilly

$238.52 /

+1.19 (+0.50%)

, BIIB

Biogen

$326.40 /

+3.46 (+1.07%)

Healthcare Analysts,…

Healthcare Analysts, along with Martin Sadowski, Professor with tenure in Depts. of Neurology, Psychiatry, and Biochemistry at NY University College of Medicine and Joshua Cohen, owner at Joshua P. Cohen Healthcare Analytics, discuss new drugs to treat Alzheimer's, including Biogen's Aduhelm and how it will fit into the treatment paradigm and how they will be reimbursed on an Analyst/Industry conference call to be held on July 23 at 11 am.

ShowHide Related Items >><<
PRTA Prothena
$51.46 /

-0.37 (-0.71%)

LLY Eli Lilly
$238.52 /

+1.19 (+0.50%)

BIIB Biogen
$326.40 /

+3.46 (+1.07%)

PRTA Prothena
$51.46 /

-0.37 (-0.71%)

07/19/21 RBC Capital
Prothena price target raised to $59 from $50 at RBC Capital
07/15/21 Cantor Fitzgerald
Prothena price target raised to $70 from $63 at Cantor Fitzgerald
07/13/21 Oppenheimer
Prothena price target raised to $76 from $54 at Oppenheimer
07/13/21 H.C. Wainwright
Prothena price target raised to $75 from $58 at H.C. Wainwright
LLY Eli Lilly
$238.52 /

+1.19 (+0.50%)

07/19/21 Goldman Sachs
Option Care Health upgraded to Buy from Neutral at Goldman Sachs
07/06/21 Barclays
Eli Lilly price target raised to $250 from $227 at Barclays
07/02/21 Truist
Eli Lilly price target raised to $262 from $225 at Truist
06/24/21 JPMorgan
JPMorgan raises Eli Lilly target to $270 after 'clear positive' donanemab news
BIIB Biogen
$326.40 /

+3.46 (+1.07%)

07/22/21 Piper Sandler
Piper Sandler ups Biogen target, remains buyer after 'strong' Q2
07/22/21 Stifel
Biogen price target lowered to $430 from $443 at Stifel
07/19/21 Baird
Biogen survey highlights uncertainty around Aduhelm launch, says Baird
07/19/21 Piper Sandler
Doctors see 'robust' uptake of Biogen's Aduhelm, says Piper Sandler
PRTA Prothena
$51.46 /

-0.37 (-0.71%)

LLY Eli Lilly
$238.52 /

+1.19 (+0.50%)

BIIB Biogen
$326.40 /

+3.46 (+1.07%)

  • 24
    Mar
LLY Eli Lilly
$238.52 /

+1.19 (+0.50%)

BIIB Biogen
$326.40 /

+3.46 (+1.07%)

PRTA Prothena
$51.46 /

-0.37 (-0.71%)

LLY Eli Lilly
$238.52 /

+1.19 (+0.50%)

BIIB Biogen
$326.40 /

+3.46 (+1.07%)

LLY Eli Lilly
$238.52 /

+1.19 (+0.50%)

BIIB Biogen
$326.40 /

+3.46 (+1.07%)

Conference/Events
Insulet to host business news update conference call » 11:55
07/22/21
07/22
11:55
07/22/21
11:55
PODD

Insulet

$272.01 /

+0.275 (+0.10%)

Conference call to review…

Conference call to review the Omnipod 5 Automated Insulin Delivery System will be held on July 22 at 12 pm. Webcast Link

ShowHide Related Items >><<
PODD Insulet
$272.01 /

+0.275 (+0.10%)

PODD Insulet
$272.01 /

+0.275 (+0.10%)

07/21/21 Cowen
Insulet price target raised to $310 from $285 at Cowen
05/27/21 Piper Sandler
Medtronic price target raised to $140 from $130 at Piper Sandler
05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
05/24/21 Barclays
Insulet initiated with an Overweight at Barclays
PODD Insulet
$272.01 /

+0.275 (+0.10%)

PODD Insulet
$272.01 /

+0.275 (+0.10%)

Conference/Events
Insulet to host business news update conference call » 04:55
07/22/21
07/22
04:55
07/22/21
04:55
PODD

Insulet

$271.22 /

-1.665 (-0.61%)

Conference call to review…

Conference call to review the Omnipod 5 Automated Insulin Delivery System will be held on July 22 at 12 pm. Webcast Link

ShowHide Related Items >><<
PODD Insulet
$271.22 /

-1.665 (-0.61%)

PODD Insulet
$271.22 /

-1.665 (-0.61%)

07/21/21 Cowen
Insulet price target raised to $310 from $285 at Cowen
05/27/21 Piper Sandler
Medtronic price target raised to $140 from $130 at Piper Sandler
05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
05/24/21 Barclays
Insulet initiated with an Overweight at Barclays
PODD Insulet
$271.22 /

-1.665 (-0.61%)

PODD Insulet
$271.22 /

-1.665 (-0.61%)

Wednesday
Periodicals
Acutus shares would be worth $28 at Atricure's valuation, Kerrisdale says » 09:26
07/21/21
07/21
09:26
07/21/21
09:26
AFIB

Acutus Medical

$13.42 /

+0.03 (+0.22%)

, ATRC

AtriCure

$79.54 /

+2.35 (+3.04%)

, BSX

Boston Scientific

$42.80 /

+1.595 (+3.87%)

, MDT

Medtronic

$125.52 /

+2.75 (+2.24%)

Kerrisdale Capital…

Kerrisdale Capital published a report outlining its long thesis on Acutus Medical (AFIB), in which the firm stated in part: "Despite operating in a multi-billion dollar market growing at high double digit rates, Acutus trades at about 8x the next twelve months' consensus revenue estimates, and at just 5x our 2022 estimate of $76M in revenues, a valuation on par with mega-cap medical device companies like Boston Scientific (BSX) and Medtronic (MDT), and a steep discount to more rapidly growing upstarts. Atricure (ATRC), the only other public company exclusively dedicated to ablation devices, trades at more than 11x consensus estimates for its 2022 revenues despite the fact that its surgical ablation end markets are growing much more slowly than the catheter ablation market, and its core products are existentially threatened by catheter ablation advances. At Atricure's valuation, Acutus shares would be worth $28, more than double their current price, and still offer the prospect of multiplying several times over as AcQMap becomes the standard of care in complex arrhythmias." In pre-market trading, Acutus shares have risen $1.25, or 9%, to $14.69. Reference Link

ShowHide Related Items >><<
MDT Medtronic
$125.52 /

+2.75 (+2.24%)

BSX Boston Scientific
$42.80 /

+1.595 (+3.87%)

ATRC AtriCure
$79.54 /

+2.35 (+3.04%)

AFIB Acutus Medical
$13.42 /

+0.03 (+0.22%)

AFIB Acutus Medical
$13.42 /

+0.03 (+0.22%)

07/15/21 Canaccord
Acutus Medical upgraded to Buy on signs of commercial traction at Canaccord
07/15/21 Canaccord
Acutus Medical upgraded to Buy from Hold at Canaccord
03/19/21 Canaccord
Acutus Medical price target lowered to $16 from $30 at Canaccord
03/19/21 William Blair
Acutus Medical downgraded to Market Perform from Outperform at William Blair
ATRC AtriCure
$79.54 /

+2.35 (+3.04%)

06/15/21 Stifel
AtriCure price target raised to $85 from $72 at Stifel
05/26/21 SVB Leerink
AtriCure price target raised to $95 from $78 at SVB Leerink
05/14/21 JPMorgan
AtriCure price target raised to $81 from $70 at JPMorgan
04/30/21 Canaccord
AtriCure price target raised to $102 from $77 at Canaccord
BSX Boston Scientific
$42.80 /

+1.595 (+3.87%)

06/07/21 Argus
Boston Scientific price target raised to $50 from $45 at Argus
05/26/21
Fly Intel: Top five analyst downgrades
05/26/21 Needham
Boston Scientific downgraded to Hold at Needham on overextended consensus
05/26/21 Needham
Boston Scientific downgraded to Hold from Buy at Needham
MDT Medtronic
$125.52 /

+2.75 (+2.24%)

07/21/21 Evercore ISI
Intuitive Surgical price target raised to $980 from $825 at Evercore ISI
06/10/21 Truist
Aziyo Biologics price target lowered to $16 from $20 at Truist
06/07/21 Piper Sandler
Piper cuts Aziyo target but sees Medtronic sticking with company
06/03/21 Piper Sandler
Piper stays Overweight Medtronic after HeartWare HVAD device discontinued
MDT Medtronic
$125.52 /

+2.75 (+2.24%)

BSX Boston Scientific
$42.80 /

+1.595 (+3.87%)

ATRC AtriCure
$79.54 /

+2.35 (+3.04%)

AFIB Acutus Medical
$13.42 /

+0.03 (+0.22%)

  • 15
    Jul
  • 06
    Aug
AFIB Acutus Medical
$13.42 /

+0.03 (+0.22%)

BSX Boston Scientific
$42.80 /

+1.595 (+3.87%)

AFIB Acutus Medical
$13.42 /

+0.03 (+0.22%)

MDT Medtronic
$125.52 /

+2.75 (+2.24%)

BSX Boston Scientific
$42.80 /

+1.595 (+3.87%)

AFIB Acutus Medical
$13.42 /

+0.03 (+0.22%)

Recommendations
Tandem Diabetes transferred with Outperform rating at Cowen » 08:47
07/21/21
07/21
08:47
07/21/21
08:47
TNDM

TNDM

/

+

Cowen analyst Joshua…

Cowen analyst Joshua Jennings assumed coverage of Tandem Diabetes with an unchanged Outperform rating and $130 price target after updating the firm's estimates. He views Tandem's sustainable double-digit revenue growth as deserving of a premium valuation, Jennings said.

ShowHide Related Items >><<
TNDM TNDM
/

+

TNDM TNDM
/

+

05/27/21 Piper Sandler
Medtronic price target raised to $140 from $130 at Piper Sandler
05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
05/24/21 Barclays
Tandem Diabetes initiated with an Underweight at Barclays
05/06/21 SVB Leerink
Tandem Diabetes price target raised to $102 from $95 at SVB Leerink
TNDM TNDM
/

+

Recommendations
DexCom price target lowered to $525 from $540 at Cowen » 08:44
07/21/21
07/21
08:44
07/21/21
08:44
DXCM

DexCom

$447.89 /

+12.61 (+2.90%)

Cowen analyst Joshua…

Cowen analyst Joshua Jennings assumed coverage of DexCom and lowered the firm's price target to $525 from $540 while keeping an Outperform rating on the shares. Jennings noted the company has one of the most attractive CGM product pipelines which targets a massive underpenetrated total addressable market. He believes new patient adds in core intensive markets and non-intensive adoption provides a pathway for strong double-digit percentage growth through 2025.

ShowHide Related Items >><<
DXCM DexCom
$447.89 /

+12.61 (+2.90%)

DXCM DexCom
$447.89 /

+12.61 (+2.90%)

07/01/21 Piper Sandler
DexCom settlement with Abbott could be lucrative, says Piper Sandler
07/01/21 Stephens
Stephens says DexCom-Abbott 'legal wrangling' unlikely resolved in short-term
06/14/21 Piper Sandler
Medicare decision to provide tailwind for DexCom, says Piper Sandler
DXCM DexCom
$447.89 /

+12.61 (+2.90%)

DXCM DexCom
$447.89 /

+12.61 (+2.90%)

DXCM DexCom
$447.89 /

+12.61 (+2.90%)

DXCM DexCom
$447.89 /

+12.61 (+2.90%)

Recommendations
Insulet price target raised to $310 from $285 at Cowen » 08:42
07/21/21
07/21
08:42
07/21/21
08:42
PODD

Insulet

$272.86 /

+7.39 (+2.78%)

Cowen analyst Joshua…

Cowen analyst Joshua Jennings assumed coverage of Insulet and raised the firm's price target to $310 from $285 while keeping an Outperform rating on the shares. The analyst raised estimates, with his revised model reflecting year-to-date operating trends and guidance for Q2 and 2021.

ShowHide Related Items >><<
PODD Insulet
$272.86 /

+7.39 (+2.78%)

PODD Insulet
$272.86 /

+7.39 (+2.78%)

05/27/21 Piper Sandler
Medtronic price target raised to $140 from $130 at Piper Sandler
05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
05/24/21 Barclays
Insulet initiated with an Overweight at Barclays
PODD Insulet
$272.86 /

+7.39 (+2.78%)

PODD Insulet
$272.86 /

+7.39 (+2.78%)

Recommendations
Intuitive Surgical price target raised to $980 from $825 at Evercore ISI » 08:27
07/21/21
07/21
08:27
07/21/21
08:27
ISRG

Intuitive Surgical

$955.39 /

+24.39 (+2.62%)

, MDT

Medtronic

$125.52 /

+2.75 (+2.24%)

Evercore ISI analyst…

Evercore ISI analyst Vijay Kumar raised the firm's price target on Intuitive Surgical (ISRG) to $980 from $825 and keeps an In Line rating on the shares. A "big beat was expected" from the company with the stock having a double-digit move up into Q2 earnings, said Kumar, who thinks Intuitive "did enough to meet and beat expectations." He struggles with the stock's multiple, noting that Intuitive currently has a market cap of about $110B and Medtronic (MDT) has a market cap of about $165B. Kumar said it is "hard for us to imagine" Intuitive' smarket cap reaching Medtronic levels given the difference in revenue bases and total addressable markets for the two.

ShowHide Related Items >><<
MDT Medtronic
$125.52 /

+2.75 (+2.24%)

ISRG Intuitive Surgical
$955.39 /

+24.39 (+2.62%)

ISRG Intuitive Surgical
$955.39 /

+24.39 (+2.62%)

07/21/21 Wells Fargo
Intuitive Surgical price target raised to $1,060 from $916 at Wells Fargo
07/21/21 Baird
Intuitive Surgical price target raised to $1050 from $825 at Baird
07/21/21 Citi
Intuitive Surgical price target raised to $1,100 from $939 at Citi
07/21/21 Piper Sandler
Intuitive Surgical price target raised to $970 from $840 at Piper Sandler
MDT Medtronic
$125.52 /

+2.75 (+2.24%)

06/10/21 Truist
Aziyo Biologics price target lowered to $16 from $20 at Truist
06/07/21 Piper Sandler
Piper cuts Aziyo target but sees Medtronic sticking with company
06/03/21 Piper Sandler
Piper stays Overweight Medtronic after HeartWare HVAD device discontinued
06/03/21 Argus
Medtronic price target raised to $150 from $135 at Argus
MDT Medtronic
$125.52 /

+2.75 (+2.24%)

ISRG Intuitive Surgical
$955.39 /

+24.39 (+2.62%)

ISRG Intuitive Surgical
$955.39 /

+24.39 (+2.62%)

ISRG Intuitive Surgical
$955.39 /

+24.39 (+2.62%)

MDT Medtronic
$125.52 /

+2.75 (+2.24%)

ISRG Intuitive Surgical
$955.39 /

+24.39 (+2.62%)

Tuesday
On The Fly
Fly Intel: Pre-market Movers » 08:56
07/20/21
07/20
08:56
07/20/21
08:56
MDWD

MediWound

$4.47 /

-0.15 (-3.25%)

, HCA

HCA Healthcare

$217.64 /

-1.63 (-0.74%)

, DOV

Dover

$151.95 /

-3.08 (-1.99%)

, KEY

KeyCorp

$18.50 /

-0.855 (-4.42%)

, CFG

Citizens Financial

$41.23 /

-1.78 (-4.14%)

, ALLY

Ally Financial

$47.98 /

-2.11 (-4.21%)

, HAL

Halliburton

$19.36 /

-0.705 (-3.51%)

, OMC

Omnicom

$76.39 /

-1.03 (-1.33%)

, IBM

IBM

$138.13 /

-0.79 (-0.57%)

, SYF

Synchrony

$44.79 /

-1.93 (-4.13%)

, PPG

PPG

$165.52 /

-4.77 (-2.80%)

, STLD

Steel Dynamics

$58.06 /

-1.8 (-3.01%)

, ARDX

Ardelyx

$7.70 /

+0.195 (+2.60%)

Check out this morning's…

ShowHide Related Items >><<
SYF Synchrony
$44.79 /

-1.93 (-4.13%)

STLD Steel Dynamics
$58.06 /

-1.8 (-3.01%)

PPG PPG
$165.52 /

-4.77 (-2.80%)

OMC Omnicom
$76.39 /

-1.03 (-1.33%)

MDWD MediWound
$4.47 /

-0.15 (-3.25%)

KEY KeyCorp
$18.50 /

-0.855 (-4.42%)

IBM IBM
$138.13 /

-0.79 (-0.57%)

HCA HCA Healthcare
$217.64 /

-1.63 (-0.74%)

HAL Halliburton
$19.36 /

-0.705 (-3.51%)

CFG Citizens Financial
$41.23 /

-1.78 (-4.14%)

ARDX Ardelyx
$7.70 /

+0.195 (+2.60%)

ALLY Ally Financial
$47.98 /

-2.11 (-4.21%)

MDWD MediWound
$4.47 /

-0.15 (-3.25%)

06/29/21 Oppenheimer
MediWound NexoBrid CRL as expected, says Oppenheimer
03/02/21 Aegis
MediWound initiated with a Buy at Aegis
02/26/21 H.C. Wainwright
MediWound price target raised to $7 from $5.50 at H.C. Wainwright
10/19/20 BTIG
Vericel price target raised to $30 from $23 at BTIG
HCA HCA Healthcare
$217.64 /

-1.63 (-0.74%)

07/19/21 Goldman Sachs
HCA Healthcare price target raised to $252 from $223 at Goldman Sachs
07/09/21 Seaport Global
Seaport initiates five in Healthcare Facilities and Services with three Buys
07/09/21 Seaport Global
HCA Healthcare initiated with a Buy at Seaport Global
05/13/21
Fly Intel: Top five analyst initiations
DOV Dover
$151.95 /

-3.08 (-1.99%)

07/14/21 Deutsche Bank
Dover price target raised to $167 from $150 at Deutsche Bank
06/14/21 JPMorgan
Dover earnings momentum intact, says JPMorgan
04/21/21 Deutsche Bank
Dover price target raised to $150 from $143 at Deutsche Bank
04/21/21 JPMorgan
Dover price target raised to $155 from $138 at JPMorgan
KEY KeyCorp
$18.50 /

-0.855 (-4.42%)

07/19/21 Odeon Capital
KeyCorp downgraded to Hold from Buy at Odeon Capital
07/16/21 Citi
KeyCorp assumed with a Neutral at Citi
07/06/21 Keefe Bruyette
KeyCorp assumed with a Market Perform at Keefe Bruyette
04/29/21 Citi
KeyCorp price target raised to $24 from $20 at Citi
CFG Citizens Financial
$41.23 /

-1.78 (-4.14%)

07/16/21 Citi
Citizens Financial assumed with a Neutral at Citi
07/06/21 Keefe Bruyette
Citizens Financial assumed with an Outperform at Keefe Bruyette
05/18/21 Compass Point
Citizens Financial price target raised to $55 from $51 at Compass Point
05/03/21 JPMorgan
Citizens Financial price target raised to $50 from $48 at JPMorgan
ALLY Ally Financial
$47.98 /

-2.11 (-4.21%)

07/05/21 BMO Capital
Santander Consumer downgraded to Market Perform from Outperform at BMO Capital
05/27/21
Fly Intel: Top five analyst initiations
05/27/21 Deutsche Bank
Ally Financial initiated with a Buy, $65 target at Deutsche Bank
05/26/21 Deutsche Bank
Ally Financial initiated with a Buy at Deutsche Bank
HAL Halliburton
$19.36 /

-0.705 (-3.51%)

07/19/21 BofA
Halliburton added to U.S. 1 List at BofA in place of Schlumberger
06/25/21 Citi
Halliburton price target raised to $28 from $27 at Citi
05/13/21 Goldman Sachs
Halliburton initiated with a Neutral at Goldman Sachs
05/03/21 Barclays
Halliburton upgraded to Overweight from Equal Weight at Barclays
OMC Omnicom
$76.39 /

-1.03 (-1.33%)

05/03/21 Macquarie
Omnicom upgraded to Outperform on 'cyclical rebound' at Macquarie
05/03/21 Macquarie
Omnicom upgraded to Outperform from Neutral at Macquarie
04/22/21 BMO Capital
Omnicom price target raised to $80 from $68 at BMO Capital
04/21/21 Wells Fargo
Omnicom price target raised to $85 from $75 at Wells Fargo
IBM IBM
$138.13 /

-0.79 (-0.57%)

07/20/21 Morgan Stanley
IBM price target raised to $164 from $152 at Morgan Stanley
07/20/21 Citi
IBM price target raised to $150 from $140 at Citi
07/20/21 Societe Generale
IBM upgraded to Hold from Sell at Societe Generale
07/16/21 BMO Capital
IBM price target raised to $155 from $150 at BMO Capital
SYF Synchrony
$44.79 /

-1.93 (-4.13%)

07/19/21 JMP Securities
Synchrony price target raised to $55 from $43 at JMP Securities
07/12/21 Wells Fargo
Synchrony price target raised to $55 from $48 at Wells Fargo
07/09/21 Barclays
Synchrony price target raised to $63 from $52 at Barclays
07/09/21 Citi
Synchrony assumed with a Neutral at Citi
PPG PPG
$165.52 /

-4.77 (-2.80%)

07/01/21 Societe Generale
PPG price target raised to $192 from $168 at Societe Generale
05/21/21 Deutsche Bank
PPG price target raised to $205 from $190 at Deutsche Bank
05/14/21 RBC Capital
PPG price target raised to $193 from $180 at RBC Capital
05/11/21 Goldman Sachs
PPG price target raised to $192 from $187 at Goldman Sachs
STLD Steel Dynamics
$58.06 /

-1.8 (-3.01%)

07/07/21 Credit Suisse
Steel demand booming in the U.S., says Credit Suisse
07/01/21 Deutsche Bank
Steel Dynamics price target raised to $72 from $68 at Deutsche Bank
06/18/21 Deutsche Bank
Steel Dynamics price target raised to $68 from $57 at Deutsche Bank
06/16/21
Fly Intel: Top five analyst initiations
ARDX Ardelyx
$7.70 /

+0.195 (+2.60%)

07/20/21 Wedbush
Ardelyx downgraded to Neutral, price cut to $3 at Wedbush
07/20/21 Ladenburg
Ardelyx price target lowered to $6.50 from $15 at Ladenburg
07/20/21 Wedbush
Ardelyx downgraded to Neutral from Outperform at Wedbush
07/20/21 Piper Sandler
Ardelyx downgraded to Neutral from Overweight at Piper Sandler
SYF Synchrony
$44.79 /

-1.93 (-4.13%)

STLD Steel Dynamics
$58.06 /

-1.8 (-3.01%)

PPG PPG
$165.52 /

-4.77 (-2.80%)

OMC Omnicom
$76.39 /

-1.03 (-1.33%)

MDWD MediWound
$4.47 /

-0.15 (-3.25%)

KEY KeyCorp
$18.50 /

-0.855 (-4.42%)

IBM IBM
$138.13 /

-0.79 (-0.57%)

HCA HCA Healthcare
$217.64 /

-1.63 (-0.74%)

HAL Halliburton
$19.36 /

-0.705 (-3.51%)

DOV Dover
$151.95 /

-3.08 (-1.99%)

CFG Citizens Financial
$41.23 /

-1.78 (-4.14%)

ARDX Ardelyx
$7.70 /

+0.195 (+2.60%)

ALLY Ally Financial
$47.98 /

-2.11 (-4.21%)

SYF Synchrony
$44.79 /

-1.93 (-4.13%)

STLD Steel Dynamics
$58.06 /

-1.8 (-3.01%)

OMC Omnicom
$76.39 /

-1.03 (-1.33%)

KEY KeyCorp
$18.50 /

-0.855 (-4.42%)

IBM IBM
$138.13 /

-0.79 (-0.57%)

HAL Halliburton
$19.36 /

-0.705 (-3.51%)

SYF Synchrony
$44.79 /

-1.93 (-4.13%)

STLD Steel Dynamics
$58.06 /

-1.8 (-3.01%)

KEY KeyCorp
$18.50 /

-0.855 (-4.42%)

IBM IBM
$138.13 /

-0.79 (-0.57%)

HCA HCA Healthcare
$217.64 /

-1.63 (-0.74%)

HAL Halliburton
$19.36 /

-0.705 (-3.51%)

DOV Dover
$151.95 /

-3.08 (-1.99%)

CFG Citizens Financial
$41.23 /

-1.78 (-4.14%)

ARDX Ardelyx
$7.70 /

+0.195 (+2.60%)

ALLY Ally Financial
$47.98 /

-2.11 (-4.21%)

SYF Synchrony
$44.79 /

-1.93 (-4.13%)

STLD Steel Dynamics
$58.06 /

-1.8 (-3.01%)

PPG PPG
$165.52 /

-4.77 (-2.80%)

IBM IBM
$138.13 /

-0.79 (-0.57%)

HAL Halliburton
$19.36 /

-0.705 (-3.51%)

DOV Dover
$151.95 /

-3.08 (-1.99%)

CFG Citizens Financial
$41.23 /

-1.78 (-4.14%)

ALLY Ally Financial
$47.98 /

-2.11 (-4.21%)

Hot Stocks
MediWound trading resumes  07:30
07/20/21
07/20
07:30
07/20/21
07:30
MDWD

MediWound

$4.47 /

-0.15 (-3.25%)

 
ShowHide Related Items >><<
MDWD MediWound
$4.47 /

-0.15 (-3.25%)

MDWD MediWound
$4.47 /

-0.15 (-3.25%)

06/29/21 Oppenheimer
MediWound NexoBrid CRL as expected, says Oppenheimer
03/02/21 Aegis
MediWound initiated with a Buy at Aegis
02/26/21 H.C. Wainwright
MediWound price target raised to $7 from $5.50 at H.C. Wainwright
10/19/20 BTIG
Vericel price target raised to $30 from $23 at BTIG
MDWD MediWound
$4.47 /

-0.15 (-3.25%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.